AP1S3 Promotes Proliferation and Invasion of Cholangiocarcinoma Cells and Modulates HER2 Trafficking
Cells · 09.11.2026 · 15 (21) · 2039
DOI: 10.3390/cells15212039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 09.11.2026. Verfasst von Chen Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha 410000, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Erb-b2 Receptor Tyrosine Kinases, Bile Duct Neoplasms. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Xisike Clinical Oncology Research Foundation, Health and Family Planning Commission of Hunan Province.
Abstract (Originalsprache)
Background
Cholangiocarcinoma (CCA) is an inflammation-associated malignancy with limited benefit from HER2-targeted therapy. Whether psoriasis is causally linked to CCA and how AP1S3 contributes remain unclear.
Methods
We performed exploratory two-sample Mendelian randomization (MR), integrated bulk and single-cell transcriptomes, and used CCA cell lines and xenografts to examine AP1S3 and HER2 trafficking.
Results
Strict MR (8 IVs; MHC excluded) gave an OR of 1.00 (95% CI 0.83–1.21; p = 0.98); the relaxed-threshold estimate (OR 1.12, 1.01–1.25; p = 0.037) was not robust (independent OR 1.05, 0.96–1.14; p = 0.30). IL-17A/TNF-α increased AP1S3 in CCA cells and activated NF-κB/RELA, but direct RELA binding was not demonstrated. AP1S3 was associated with a SCEL+ squamous-like program. AP1S3 co-precipitated with HER2 via EIPDLL (residues 930–935, kinase domain) and modulated HER2 trafficking; direct binding, isoform specificity and active recycling were not established.
Conclusions
The psoriasis–CCA association is inconclusive. AP1S3 is a candidate inflammatory regulator of HER2 trafficking and requires direct binding, loss-of-function and clinical validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha 410000, China.
ORCID-Profile: Ronglin Xu
Förderung
- National Natural Science Foundation of China
- Beijing Xisike Clinical Oncology Research Foundation
- Health and Family Planning Commission of Hunan Province
- Health Research Project of Hunan Provincial Health Commission
Zitieren
APA
Shen, C., Xu, R., Zhou, H., Wang, Y., Liu, Z., Xin, Y., Wang, T., Zou, H., Zhang, Z., & Wen, Y. (2026). AP1S3 Promotes Proliferation and Invasion of Cholangiocarcinoma Cells and Modulates HER2 Trafficking. Cells, 15(21), 2039. https://doi.org/10.3390/cells15212039
Vancouver
Shen C, Xu R, Zhou H, Wang Y, Liu Z, Xin Y, et al. AP1S3 Promotes Proliferation and Invasion of Cholangiocarcinoma Cells and Modulates HER2 Trafficking. Cells. 2026;15(21):2039. doi:10.3390/cells15212039
BibTeX
@article{Shen2026,
author = {Shen, Chen and Xu, Ronglin and Zhou, Hui and Wang, Yongxiang and Liu, Zhongtao and Xin, Yang and Wang, Tiantian and Zou, Heng and Zhang, Zijian and Wen, Yu},
title = {AP1S3 Promotes Proliferation and Invasion of Cholangiocarcinoma Cells and Modulates HER2 Trafficking},
journal = {Cells},
year = {2026},
volume = {15},
number = {21},
pages = {2039},
doi = {10.3390/cells15212039}
}
EUVIMED